Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs MobilEye Global Inc (MBLY) Price & Performance

Cronos Group IncTrade
MobilEye Global IncTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs MobilEye Global Inc — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.14B), while MobilEye Global Inc trades at $8.9 (market cap $7.54B). The key difference: MobilEye Global Inc is far larger — about 6.6× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals.

CRONMBLY
Market Cap
$1.14B$7.54B
Sector
HealthTechnology
52-Week High
$3.27$15.54
52-Week Low
$2.30$6.56
Enterprise Value
$341.13M$6.10B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON

About MobilEye Global Inc

Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.

Read more on MBLY